Macular Degeneration Association (MDA) 2011 Educational Symposium New Treatments For Wet And Dry Macular Degeneration

Top Quote An educational symposium covering macular degeneration treatments will be held in Winter Haven, Florida on April 30th, 2011. End Quote
  • Sarasota-Bradenton, FL (1888PressRelease) April 23, 2011 - The Macular Degeneration Association, Drs. Phillips, Salomon and Parrish, Eye Express, Center for Retina and Macular Disease and Eye Solutions are hosting a spring educational symposium on April 30, 2011. The event will take place at the Best Western Park View Hotel in Winter Haven, Florida. The symposium is an excellent opportunity for participants to learn about the latest advances in macular degeneration treatments and therapy innovations that will greatly improve quality of life.

    The event will feature several prominent figures in the macular field, including Program Chair Dr. Michael Tolentino, a pioneer in the treatment of macular degeneration. Dr. Tolentino is a specialist at the Center for Retina and Macular Disease (CRMD) and can be credited with helping to develop all current treatments for wet macular degeneration and diabetic retinopathy, including Avastin, Lucentis, Macugen and Verteporfin. Dr. Tolentino was the first in the world to test Avastin in a model of eye disease 15 years ago. He has more than 80 peer-reviewed publications and five issued patents. As a clinical investigator he has been principal investigator on over 70 clinical research studies evaluating new treatments for wet and dry macular degeneration and diabetic retinopathy. He has delivered over 100 lectures in over 15 countries on new therapies for macular degeneration and diabetic retinopathy.

    At the symposium, Dr. Tolentino will present his research related to new macular degeneration treatments. Several others in the macular field will present educational lectures, including local optometrist Dr. Greg Parrish. All speakers will make themselves available to the patients by actively participating in a panel discussion. This event is a unique opportunity to learn about the latest advances in macular degeneration research, genetic testing, medications, treatments, and therapies. Participants are encouraged to share questions, concerns and ideas with nationally known macular experts, local doctors, patients and caregivers.

    Program Topics include:
    What is Macular Degeneration?
    The Importance of a Comprehensive Eye Exam
    Macular Degeneration Genetic Testing
    Current Treatments for Wet Macular Degeneration
    Panel Discussion with Program Speakers

    About the Macular Degeneration Association (MDA)

    The Macular Degeneration Association (MDA) is a nonprofit health organization dedicated to educating and empowering age-related macular degeneration patients all across the world.

    Age-related macular degeneration is an increasingly prevalent degenerative eye disease, affecting millions of aging seniors. The mission of MDA is to educate patients on the latest advances in treating age-related macular degeneration (AMD). However, our focus extends far beyond diagnosed patients. We are committed to the senior population at large, those most at risk of developing macular degeneration.

    Our goal is to provide information about risk factors, genetic predisposition, and proper diagnosis, as well as preventative efforts and treatment options that will likely reduce the most adverse effect of AMD, blindness.

    MDA is passionate about funding and developing sophisticated patient education and advocacy programs designed to improve macular patients' quality of life. This is accomplished through the MDA's patient education conferences and seminars held nationwide.

    The Association honors its commitment to prioritizing patient education by aligning itself with experts in the macular field, investigating retina-related scientific breakthroughs, and disseminating new scientific advances to macular patients across the world.

    We strongly believe that providing support, education and empowerment to the millions of people living with age-related macular degeneration will improve patient quality of life, and energize the retina field to develop advances in treating AMD. It is our hope that encouraging knowledge and awareness will ultimately lead to a cure.

    The money raised by the foundation funds research, information programs, advocacy and awareness efforts that will support the over 9.1 million people with macular degeneration in communities across America. For more information, please visit our website at

    To register for the April 30th Educational Symposium in Winter Haven, please visit

    For more information, contact Ms. Donna Auger at: dauger ( @ ) maculargdegenerationassociation dot org or call (941)870-4399 dot

    Thank you for your interest and support.

  • FB Icon Twitter Icon In-Icon
Contact Information